Clarke’s arguments in favour of permitting conscientious objection (CO) in healthcare and setting up registries are not new, but the consequentialist basis for them and the careful attention to ...

Colgrove and Rodger argue that the case advanced by Smajdor and Räsänen for classifying pregnancy as a disease can be defeated by an existence proof—that is, by identifying at least one plausible ...

1 Department of Deontology and History of Medicine, Cukurova University, Adana, Turkey 2 Cukurova University Adana Health High School, Department of Midwifery, Adana, Turkey Correspondence to Dr Hasan ...

There is a long history of medical research that involves intentionally infecting healthy people in order to study diseases and their treatments. Such research—what might be called “human challenge ...

The development of the fifth edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders—the DSM-5—has reenergised and driven further forward critical ...

NIEHS, National Institutes of Health, Research Triangle Park, North Carolina, USA Correspondence to Dr David B Resnik, NIEHS, National Institutes of Health, Research Triangle Park, Box 12233, Mail ...

In an online study conducted separately in the UK and the US, participants rated the acceptability and fairness of four interventions: two types of financial incentives (rewards and penalties) and two ...

1 Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA Objective To evaluate the relationship between recently trained paediatricians' ...

We are printing, by kind permission of the Law Commission, two sections of the report of the Law Commission on injuries to unborn children. This report was the result of a request to the Law ...

Correspondence to: Vittorio Fineschi Institute of Legal Medicine, University of Foggia, Ospedali Riuniti, Via L Pinto, no 1, 71100 Foggia, Italy; vfinesctin.it The Italian parliament passed the law on ...

Background: The Directive 2001/20/EC was an important first step towards consistency in the requirements and processes for clinical trials across Europe. However, by applying the same rules to all ...